Drug maker Aspen names new chairwoman

JOHANNESBURG – Africa’s biggest generic drug maker, Aspen, yesterday said Judy Dlamini would replace Archie Aaron as the new chairperson after the firm’s November annual general meeting.

Aaron was appointed as chairman in 1999 and would remain as a non-executive director of the firm. Dlamini, a medical doctor, was appointed to the Aspen board in 2005, following black investment firm Imithi’s investment in the drug manufacturer.The SA government has been encouraging companies to offer stakes to blacks and to accelerate equity in a bid to encourage them into the mainstream economy following the exclusion of blacks under white apartheid rule.Nampa-ReutersDlamini, a medical doctor, was appointed to the Aspen board in 2005, following black investment firm Imithi’s investment in the drug manufacturer.The SA government has been encouraging companies to offer stakes to blacks and to accelerate equity in a bid to encourage them into the mainstream economy following the exclusion of blacks under white apartheid rule.Nampa-Reuters